CVE-2026-68067Mira Hormone Monitor, Mira Android App Weak Authentication
Updated under an hour ago ()
Does this affect you?
It affects Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.
- CVSS
- 9.8 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-1390
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- icscert
- NVD analysis
- Deferred
- Record last updated
- Aug 12, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware quanovate_tech_inc_operating_as_mira_mira_care:mira_firmware (from the name) | 1.7.1.47 | CNA record |
Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Android App quanovate_tech_inc_operating_as_mira_mira_care:mira_android_app (from the name) | 4.5.15.4 | CNA record |
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-01
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-223-01.json
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.